This paper discusses vector control strategies for single-phase motor drive systems operating with two windings. A model is proposed and used to derive control laws for single-phase motor drive ...

In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...

The data were presented during a late-breaking clinical trials session at the European Renal Association (ERA) Congress in Vienna, Austria. The study, the largest Phase 3 IgAN trial conducted to date, ...

In multiphase induction motors the number of slots per pole per phase comes down due to the higher number of phases, which results the airgap MMF per phase closer to square wave. In addition, as the ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 ...

Data from the ongoing Phase 1 monotherapy dose escalation and dose expansion portion of the study as of the data cut-off date of April 1, 2025, include results from 89 patients across six dose cohorts ...

They belong to space group C2 but have cell axes a = 85.3 Å, b = 49.9 Å and c = 54.3 Å. Data collection and processing. All date were collected at 100 K using a MAR Research imaging plate detector.

On ASCO Day 3, AstraZeneca is dominant (again), Protagonist Therapeutics and Takeda review blood cancer data, and more.

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of ...

HARMONi-2 is an ongoing China phase 3 trial in first-line, PD-L1-positive NSCLC. The trial has met its PFS endpoint, with its overall survival data remaining immature .